Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1

Virology Journal

Volumn 8, Issue , 2011, Pages

  Liu, Xin Sheng ^a   Wang, Yong Lu ^a   Zhang, Yong Guang ^a   Fang, Yu Zhen ^a   Pan, Li ^a   Lu, Jian Liang ^a   Zhou, Peng ^a   Zhang, Zhong Wang ^a   Jiang, Shou Tian ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLTYROSYLHISTIDYLLYSYLGLYCYLPROLYLPHENYLALANYLTHREONYLARGINYLLEUCINE; EPITOPE; GAMMA INTERFERON; GLYCYLPHENYLALANYLISOLEUCYLMETHIONYLASPARTYLARGINYLPHENYLALANYLVALYLLYSYLISOLEUCINE; PROTEIN VP1; UNCLASSIFIED DRUG; CAPSID PROTEIN; PEPTIDE; VIRUS ANTIBODY; VIRUS ANTIGEN; VP1 PROTEIN, FOOT AND MOUTH DISEASE VIRUS; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELL ISOLATION; CODON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SPLEEN LYMPHOCYTE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; CATTLE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE; SPLEEN; SYNTHESIS; VACCINATION; VIROLOGY;

ESCHERICHIA COLI; FOOT-AND-MOUTH DISEASE VIRUS; MUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CAPSID PROTEINS; CATTLE; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PEPTIDES; SPLEEN; VACCINATION;

EID: 80052606834     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-426     Document Type: Article

References (44)

1. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Xiao C, Rajput ZI, Hu S, Vaccine 2007 25 25 4795 4800 10.1016/j.vaccine.2007.04.027 17509735 (Pubitemid 46818618)
2. Comparative genomics of foot-and-mouth disease virus. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL, J Virol 2005 79 6487 6504 10.1128/JVI.79.10.6487-6504.2005 15858032 (Pubitemid 40617252)
3. Global epidemiology and prospects for control of foot-and-mouth disease. Kitching RP, Curr Top Microbiol Immunol 2005 288 133 148 10.1007/3-540-27109-0-6 15648177 (Pubitemid 39657081)
4. Molecular epidemiology of foot-and-mouth disease virus. Knowles NJ, Samuel AR, Virus Research 2003 91 65 80 10.1016/S0168-1702(02)00260-5 12527438 (Pubitemid 36078431)
5. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Nature 1982 298 5869 30 33 10.1038/298030a0 7045684 (Pubitemid 12087468)
6. Protection of cattle against foot-and-mouth disease by a synthetic peptide. DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N, Science (New York, NY) 1986 232 4750 639 641 10.1126/science.3008333 (Pubitemid 16061973)
7. Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. Kitson JD, Burke KL, Pullen LA, Belsham GJ, Almond JW, Journal of Virology 1991 65 6 3068 3075 1709696
8. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Wong HT, Cheng SC, Chan EW, Sheng ZT, Yan WY, Zheng ZX, Virology 2000 278 1 27 35 10.1006/viro.2000.0607 11112477 (Pubitemid 32002590)
9. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Rodriguez LL, Barrera J, Kramer E, Lubroth J, Brown F, Golde WT, Vaccine 2003 21 25-26 3751 3756 10.1016/S0264-410X(03)00364-5 12922108 (Pubitemid 37338202)
10. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. Collen T, DiMarchi R, Doel TR, J Immunol 1991 146 2 749 755 1702816
11. Antigenic specificity of porcine T cell response against foot-and- mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodriguez A, Saiz JC, Novella ZS, Virology 1994 205 24 33 10.1006/viro.1994.1616 7526534
12. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV O1 Campos. Zamorano P, Wigdorovitz A, Chaher MT, Virology 1994 201 2 383 387 10.1006/viro.1994.1305 8184548 (Pubitemid 24187285)
13. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. van Lierop MJ, Wagenaar JP, van Noort JM, Hensen EJ, J Virol 1995 69 4511 4514 7769713
14. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide. Wang JL, Liu MQ, Han J, Vet Microbiol 2007 125 224 231 10.1016/j.vetmic.2007.05.033 17656048 (Pubitemid 47588662)
15. Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Toja M, Escarmís C, Domingo E, Virus Res 1999 64 2 161 171 10.1016/S0168-1702(99)00089-1 10518712 (Pubitemid 29460725)
16. Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. Blanco E, McCullough K, Summerfield A, Virol 2000 74 10 4902 4907 10.1128/JVI.74.10.4902-4907.2000 (Pubitemid 30237922)
17. Detectionand characterization of functional T-Cell epitopes on the structural proteins V2, VP3, and VP4 of foot and mouth disease virus O1Campos. Filgueira MP, Wigdorovitz A, Romera A, Virology 2000 271 234 239 10.1006/viro.2000.0281 10860876 (Pubitemid 30461300)
18. Serological and cellular immune responses to non-structural proteins in animals infected with FMDV. Foster M, Cook A, Cedillo L, Parkhouse RM, Vet Q 1998 20 Suppl 2 28 S30 9652061
19. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. Blanco E, Garcia-Briones M, Sanz-Parra A, Virol 2001 75 7 3164 3174 10.1128/JVI.75.7.3164-3174.2001 (Pubitemid 32225880)
20. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. García-Briones, Blanco Esther, Chiva Cristina, Virology 2004 322 264 275 10.1016/j.virol.2004.01.027 15110524 (Pubitemid 38521141)
21. Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine. Gerner Wilhelm, Denyer Michael S, Takamatsu Haru-Hisa, Virus Research 2006 121 223 228 10.1016/j.virusres.2006.05.006 16934904 (Pubitemid 44436621)
22. Reconstruction of a swine SLA-I protein complex anddetermination of binding nonameric peptides derived from the foot-and-mouth disease virus. Gao Feng-Shan, Fang Qin-Mei, Li Yun-Gang, Li Xin-Sheng, Hao Hui-Fang, Xia Chun, Veterinary Immunology and Immunopathology 2006 113 328 338 10.1016/j.vetimm. 2006.06.002 16870265 (Pubitemid 44287088)
23. Molecular basis of pathogenesis of FMDV. Mason Peter W, Grubman Marvin J, Baxt Barry, Virus Research 2003 91 29 32
24. Immunology of foot-and-mouth disease. McCullough KC, Sobrino F, Foot and Mouth Disease: Current Perspectives 2004. Horizon Bioscience, Wymondham, Norfolk, England 173 222
25. Immuno-informatics: Mining genomes for vaccine components. De Groot Anne S, Sbai Hakima, Aubin Saint Caitlin, McMurry Julie, Martin William, Immunology and Cell Biology 2002 80 255 269 10.1046/j.1440-1711.2002.01092.x 12067413 (Pubitemid 34639376)
26. + T cell epitope from over-expressed antigen COX-2 in esophageal carcinoma. Gao Yan-feng, Sun Zhan-qiang, Qi Feng, Qi Yuan-ming, Zhai Ming-xia, Lou Hui-ping, Chen Li-xiang, Li Yong-xin, Wang Xian-yuan, Cancer Letters 2009 284 55 61 10.1016/j.canlet. 2009.04.009 19423214
27. + T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice. Ochoa-Callejero L, Otano I, Vales A, Olagüe C, Sarobe P, Lasarte JJ, Prieto J, Menne S, González-Aseguinolaza G, Vaccine 2010 28 5323 5331 10.1016/j.vaccine.2010.05.043 20665977
28. Identification of Immunodominant B- and T-Cell Combined Epitopes in Outer Membrane Lipoproteins LipL32 and LipL21 of Leptospira interrogans. Lin Xu'ai, Zhao Jinfang, Qian Jing, Mao Yafei, Pan Jianping, Li Liwei, Peng Huiqin, Luo Yihui, Yan Jie, Clinical and Vaccine Immunology 2010 17 778 783 10.1128/CVI.00405-09 20237196
29. Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination. Suzuki Daisuke, Nagata Toshi, Eweda Ghada, Matsumoto Sohkichi, Matsumoto Makoto, Tsujimura Kunio, Koide Yukio, Vaccine 2010 28 2020 2025 10.1016/j.vaccine.2009.10.062 20188258
30. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer. Yokouchi H, Chamoto K, Wakita D, Cancer Sci 2006 97 2 148 154 10.1111/j.1349-7006.2006.00149.x 16441426 (Pubitemid 43379483)
31. Identification of two naturally presented MAGE antigenic peptides from a patient with hepatocellular carcinoma by mass spectrometry. Zhou M, Peng J, Zhang H, Immunol Lett 2005 99 1 113 121 10.1016/j.imlet.2005.02.007 15885805 (Pubitemid 40718942)
32. + T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Jaramillo A, Majumder K, Manna P, Int J Cancer 2002 102 5 499 506 10.1002/ijc.10736 12432553 (Pubitemid 35316005)
33. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Gricks C, Rawlings E, Foroni L, Cancer Res 2001 61 13 5145 5152 11431353 (Pubitemid 32681547)
34. Comparison of synonymous codon distribution patterns of bacteriophage and host genomes. Kunisawa T, Kanaya S, Kutter E, DNA Res 1998 5 6 319 321 10.1093/dnares/5.6.319 10048480
35. Codon contexts in enterobacterial and coliphage genes. Gouy M, Mol Bio Evol 1987 4 4 426
36. Aminoacylation of tRNAs encoded by Chlorella virus CVK2. Nishida K, Kawasaki T, Fujie M, Virology 1999 263 1 220 10.1006/viro.1999.9949 10544096 (Pubitemid 29493632)
37. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR, J Immunol 1997 158 4 1507 1515 9029084 (Pubitemid 127469502)
38. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, J Immunol 1994 153 12 5586 5592 7527444 (Pubitemid 24377694)
39. Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins. Schmittel A, Keilholz U, Bauer S, Kuhne U, Stevanovic S, Thiel E, Scheibenbogen C, J Immunol Methods 2001 247 1-2 17 24 10.1016/S0022-1759(00) 00305-7 11150533 (Pubitemid 32057040)
40. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. Quiding M, Granstrom G, Nordstrom I, Ferrua B, Holmgren J, Czerkinsky C, Clin Exp Immunol 1993 91 1 157 63 8093434 (Pubitemid 23028016)
41. Molecular basis of pathogenesis of FMDV. Mason Peter W, Grubman Marvin J, Baxt Barry, Virus Research 2003 91 29 32
42. Evolution of foot-and-mouth disease virus. Domingo Esteban, Escarmís Cristina, Baranowski Eric, Ruiz-Jarabo Carmen M, Carrillo Elisa, Nú̃ez Ignacio Juan, Sobrino Francisco, Virus Research 2003 91 47 63 10.1016/S0168-1702(02)00259-9 12527437 (Pubitemid 36078430)
43. Molecular epidemiology of foot-and-mouth disease virus. Knowles NJ, Samuel AR, Virus Research 2003 91 65 80 10.1016/S0168-1702(02)00260-5 12527438 (Pubitemid 36078431)
44. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. KC Parker, Bednarek MA, Coligan JE, J Immunol 1994 152 163 167 8254189